William S Mow

Title: Innovations by William S. Mow in Crohn's Disease Diagnosis

Introduction

William S. Mow is an accomplished inventor based in Culver City, CA, with a focus on medical innovations. He holds two patents that contribute significantly to the understanding and diagnosis of Crohn's disease. His work aims to improve patient outcomes through advanced diagnostic methods.

Latest Patents

Mow's latest patents revolve around methods of assessing Crohn's disease patient phenotype by I2 serologic response. The invention provides a method for diagnosing or predicting susceptibility to a clinical subtype of Crohn's disease by determining the presence or absence of IgA anti-I2 antibodies in a subject. The presence of these antibodies indicates that the subject has a specific clinical subtype of Crohn's disease. Additionally, the method may involve determining the presence of a NOD2 variant, anti-antibodies (ASCA), IgA anti-OmpC antibodies, or perinuclear anti-neutrophil cytoplasmic antibodies (pANCA). These methods can be utilized to diagnose or predict susceptibility to various clinical subtypes of Crohn's disease, including fibrostenotic subtypes and those requiring small bowel surgery.

Career Highlights

Throughout his career, Mow has worked with notable institutions, including Cedars-Sinai Medical Center. His contributions to medical research and innovation have been instrumental in advancing the field of gastroenterology.

Collaborations

Mow has collaborated with esteemed colleagues such as Eric A. Vasiliauskas and Huiying Yang, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

William S. Mow's innovative approaches to diagnosing Crohn's disease exemplify the importance of research and development in the medical field. His patents reflect a commitment to improving patient care and advancing medical science.